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Abstract
Alcohol abuse is an important public health problem. In Portugal with a population of 10 millions of inhabitants, there are around 10%
of alcoholics or excessive alcohol drinkers and 1% of chronically infected patients with hepatitis B virus (HBV). To examine the charac-
teristics of patients with higher levels of alcohol consumption and to investigate the association between alcohol consumption and liver
damage a total of 298 chronically infected individuals, with HBV genotyped and submitted to liver biopsy, were classified with Child’s
grading and separated by habits of alcohol intake, less and greater than 20 g/day. No significant differences were observed about genotype
but genotypes A and D were predominant in both of them. A higher percentage of males (P! .001) were observed in the group with
alcohol intake above 20 g/day, as well a lower proportion of patients with HBeAg negativity (P# .035). In this group, biochemistry param-
eters, such as alanine aminotransferase (P5 .006), aspartate aminotransferase (P5 .001), gamma-glutamyl transferase (P! .001) were
elevated in a significantly higher proportion than in the other group. The analysis of hematological parameters showed significantly lower
values of platelets (P5 .042) and mean corpuscular volume (P! .001) and significantly higher values of prothrombin time (P! .001) in
the group with higher levels of alcohol consumption. The characteristics of biopsy (P! .001) and ChildePhug’s classification (P5 .002)
revealed more severe results in this group. Logistic regression showed a positive association between liver damage and alcohol intake,
increasing with age. In female patients, a strong positive association between alcohol intake and liver damage was also found (odds ratio:
9.379; 95% confidence interval: 0.859e468.422; P 5 .037); however, the most severe cases were only observed in women older than 45
years. In patients with HBV infection, alcohol is associated with a more severe liver disease. No evidence was found concerning association
with HBV genotype.  2010 Elsevier Inc. All rights reserved.
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Introduction
Alcohol abuse is an important public health problem
with a significant morbidity and mortality (Gramenzi et al.,
2006). Alcohol consumption in Portugal is 15% higher than
in the rest of Europe. It is estimated that there are approx-
imately 1 million alcoholics or excessive alcohol drinkers
in Portugal (WHO, 2008b). A study conducted in 2003
by World Health Organization (WHO) showed an annual
pure alcohol consumption of 9.49 liters per capita (WHO,
2008a). A Portuguese study confirmed that there are around
1 million of alcoholics or excessive alcohol drinkers (Pinto,
2000). According to WHO, in Portugal in the year 2004
the standardized death rate for chronic liver disease and
cirrhosis, all ages, per 100,000 was 13.31 (WHO, 2009).
The fact that Portugal had such a high liver diseaseerelated
mortality is not surprising, since Portugal was the fifth
alcohol consumer in the world (Spirits, 2002).
Several epidemiologic studies suggest that chronic alco-
holics are at risk of viral infections. Clinical and basic
research has demonstrated that alcohol not only worsens
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the natural history of chronic viral hepatitis, like hepatitis B
virus (HBV) but also seems to interact with the viral repli-
cation cycle leading to an unusual serum virologic profile
and/or modification in the serum concentration of viral
particles (Nalpas et al., 1998).
HBV is a major cause of hepatocellular carcinoma (HCC)
in the world (Wang et al., 2003). The infection with HBVand
its interaction with alcohol consumption are very well docu-
mented, and it is possible to verify that the progression to
more severe liver disease is very rapid and aggressive. In
a physiological way, it was demonstrated that several signals
activated by HBV X protein are potentiated cooperatively by
alcohol, including tumor necrosis factor-alpha and ethanol-
induced apoptosis by a caspase-3-dependent mechanism.
Those mechanisms could be implicated in the synergistic
effect of alcohol drinking and viral hepatitis on liver injury
(Gao, 2002). In the transgenic mice model, viral replication
is enhanced by alcohol consumption (Larkin et al., 2001),
suggesting that alcohol upregulates HBV gene expression
and replication. This would promote not only higher viral
loads but also trigger an antiviral immune response leading
to severe bouts of liver disease.
Several studies (Saunders et al., 1983) have shown that
patients with alcoholic cirrhosis showed evidence of past
or current infection with HBV more commonly than did
healthy nonalcoholic subjects (Bassendine et al., 1983;
Goudeau et al., 1981; Inoue, 1977; Mills et al., 1981). A
longitudinal study of hepatitis B surface antigenepositive
healthy blood donors tested in Japan between 1972
and 1975 found that alcohol consumption greater than
27 g/day (duration of alcohol use not stated) was associated
with more than a fivefold increase in the relative risk for
development of HCC (Oshima et al., 1984). A study that
compared two case series suggested that patients with
HCC caused by chronic HBV and chronic alcohol are
approximately 10 years younger than patients with HCC
caused by chronic HBV alone (Ohnishi et al., 1982; Pereira
et al., 1994).
A caseecontrol study, performed in Albania, showed that
individuals with HBV infection and excessive alcohol intake
had an increased probability (odds ratio [OR]: 26.9; 95%
confidence interval [CI]: 4.9e147) of developing chronic
hepatitis and cirrhosis when compared with patients without
these or other liver disease. Although not significant, interac-
tion was suggested between HBsAg and alcohol intake (Kon-
dili et al., 1998). A study among the Portuguese population
also found that alcohol intake was the most important risk
factor to HCC, with a frequency of 5.2% in patients with alco-
holic hepatic cirrhosis (Oliveira et al., 2001).
The sudden increase in alcoholic liver disease among
women showed their susceptibility to the hepatotoxic effects
of alcohol. Women tended to present more severe liver
disease than men, particularly alcoholic hepatitis, and did
so after a shorter period of excessive drinking and at a lower
daily alcohol intake. Differences in body size and composi-
tion may be partly responsible for the greater susceptibility
of women but differences in immune reactivity between the
sexes may also play a part (Saunders et al., 1981).
The aim of this study was to assess the characteristics of
patients with hepatitis B infection with higher levels of
alcohol consumption in the northern region of Portugal,
and to investigate the association between alcohol consump-
tion and liver damage, considering gender and genotype
differences.
Material and methods
Patients
Most of the patients with hepatitis B infection (docu-
mented because of the presence of HBsAg in serum for at
least 6 months) from the North of Portugal are treated in
three hospitals in the city of Oporto: Hospital de Sa˜o Joa˜o,
Hospital de Santo Anto´nio, and Hospital Joaquim Urbano.
The patients of this study were observed in the Hospital
de Santo Anto´nio and Hospital Joaquim Urbano. The study
was approved by the Health Ethics Committee of Hospital
de Santo Anto´nio, and written consent was obtained from
all participants. HBV genotypes were determined in 298
patients using a molecular method. Histologic evaluation
was performed in all of them. Only individuals who were
older than 16 years were included in this study. In Portugal,
since 2002 the law forbids sale of alcoholic drinks to indi-
viduals less than 16 years.
Clinical findings
Information relating to patient demographics, biologic,
histologic, and medical history was recorded from medical
files. Demographic characteristics include the following:
age, gender, place of birth, and residence, as well as marital
status. The presumed sources of HBV infection were
recorded. According to information provided by the physi-
cians, this classification is based on the patient clinical story
and the answers to a set of questions. The presumed source
of HBV infection is classified as sexual transmission when
the physician has no doubt about this source. The intrafami-
lial transmission presumed source is considered when trans-
mission seems to occur inside the family group but not
necessarily by sexual way, and there is no evidence of other
ways of transmission.
Alcohol consumption was also evaluated and catego-
rized as less than 20 g/day and greater than 20 g/day, based
on the WHO classification and other important references
in this area (Anderson, 1996a, b; Dawson, 2000; Fiellin
et al., 1998).
Detection of virologic markers in serum
The study population was tested routinely for HBsAg,
anti-HBs, and anti-HBc. HBeAg and anti-HBe antibody
were also evaluated using Vitros ECI (Ortho-Clinical Diag-
nostics, Amersham, Buckinghamshire, UK).
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HBV DNA quantification
HBV DNA levels were determined using VERSANT
HBV DNA 3.0 assay (bDNA) (Bayer, Tarrytown, NY,
USA), which is a signal amplification nucleic acid probe
assay for the direct quantification of human hepatitis B viral
DNA in HBV-infected patients. The quantification range
of the assay is from 2,000 to 100,000,000 HBV DNA
copies/mL. Values below the lower quantification limit
are reported as ‘‘!2,000’’ HBV DNA copies/mL noted
as ‘‘virus not detected.’’
HBV genotyping
HBV genotypes were determined by the TRUGENEHBV
genotyping kit. When used in conjunction with OpenGene
DNA Sequencing System (Bayer) the kit provides a method
to obtain bidirectional sequence from overlapping surface
antigen and from domains B to E of reverse transcriptase
region of HBV. The HBV DNA sequences are queried against
a library of known genotypes and mutations to deliver
a TRUGENE HBV genotyping report.
Liver enzymes and other blood parameters
Numerous biochemical tests that detect abnormal liver
function can help in the confirmation of the presence of
liver disease but cannot define the cause. The most common
blood tests that assess liver function include the following:
alanine aminotransferase (ALT) with reference values of
10e36 U/L at 37C and aspartate aminotransferase (AST)
with reference values of 10e30 U/L at 37C, which are
contained within the liver cells. Inflammation of the liver
causes these enzymes to be released in the blood in abnor-
mally high amounts. Blood levels of these two enzymes are
roughly elevated in proportion to the degree of liver
damage. The other blood test performed for detection of
eventual liver damage was gamma-glutamyl transpeptidase
(GGT) with reference values of 10e66 U/L at 37C, alka-
line phosphatase (AP) with reference values of 45e
122 U/L at 37C, and alpha-fetoprotein with reference
values less than 10.9 ng/mL. To investigate liver enzymes,
elevated levels were separated from normal levels. All
parameters were performed with Cobas Integra 800 (Roche,
Mannheim, Germany).
Hematological parameters like mean corpuscular volume
(MCV) and platelets were also evaluated, with normal levels
respectively, between 80 and 100 fL and between 150 and
400 109/L; both evaluated with Advia 120 (Bayer).
Prothrombin time (PT) was performed in ACL TOP (Instru-
mentation Laboratory Company, Lexington, MA, USA).
Liver biopsy
In the group of individuals with information about histo-
logic lesions, the following characteristics of liver disease
were evaluated: necroinflammatory, fibrosis, and esteatosis.
ChildePugh classification
Assessment of liver damage was evaluated when genotyp-
ing was performed. Child’s grading of disease severity in
chronic liver disease was classified with Pugh’s 1973 modifi-
cations (Pugh et al., 1973) based on information recorded
from medical files. This classification has three grades, from
A to C: grade C is the severest, corresponding to an overall
5-year mortality of 88%, grade B to 38%, and grade A to
29%. Because this classification is used to assess the prog-
nosis of chronic liver disease, mainly cirrhosis, in these
studies, three categories were considered to evaluate liver
damage in the studied population: (1) Child grade C, (2)
Child grade B, and (3) others, including patients classified
as Child grade A and patients without liver disease reported.
Statistical analysis
The distribution of viral load and PT was logarithmically
transformed. The results are given as geometric means with
95% CI. For the other quantitative variables, results are given
as arithmetic means with 95% CI. t-Test for independent
samples was used to compare the groups defined as alcohol
intake under or above 20 g/day. Qualitative variables were
described as percentage and compared using the Pearson
chi-square test (with continuity correction) as appropriate or
by Fisher exact test. Variability in the number of participants
included in the analyses is because of incomplete data sets.
The association between alcohol intake and liver damage
was analyzed separately for male and female patients.
For the male patients, the statistical analysis of the associ-
ation between alcohol intake and the binary outcome (Child’s
grade equivalent C or B vs. others, including patients classi-
fied as Child grade A and patients without liver disease
reported, as reference) was performed using logistic regres-
sion analysis. Two models were created for the regression
analyses. The crude model consisted only of the dependent
variable and alcohol intake group as independent variable,
whereas in the adjusted model the effect of alcohol intake
was corrected for age. Hepatitis B genotype was not included
because of not being statistically significant. To analyze the
possible difference in the association between the outcome
and alcohol intake with age, an interaction term was added.
For the interaction term a P value lower than .10 was consid-
ered to be significant. The continuous variable modeling of
age was tested through the fractional polynomial method;
a procedure that makes use of the full information available
in the data when a linear relationship is not assumed (Royston
and Altman, 1994). Fractional polynomial modeling
confirmed that the association with age was linear. The
HosmereLemeshow goodness of fit test was used to check
the lack of fit of the final logistic model.
In female patients, only five cases were classified as
Child’s grade equivalent C or B. Because of this reduced
number, the association between alcohol intake and the
binary outcome, Child’s grade equivalent C or B versus
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Child’s grade equivalent A, and patients without liver
disease reported, was analyzed considering Fisher exact
test and an exact method to construct confidence limits
for OR. Female patients were divided according to their
median age (45 years old) to analyze the possible difference
in the association between the outcome and alcohol intake
with age.
Statistical analysis was performed with SPSS (version
16.0) and STATA (version 9.0) and two-sided significance
of 5% was used throughout.
Results
Table 1 shows a description of the total studied sample
(n5 298) by alcohol intake levels: 52.0%, less than
20 g/day (n5 155) and 48.0% greater than 20 g/day
(n5 143). No significant differences between the study
groups were observed with respect to genotype distribution
and age. Genotypes A and D were predominant in both
groups of individuals. However, a significantly higher
percentage of males (P! .001) were observed in the group
Table 1
Characteristics of individuals according to alcohol intake
Chacteristics
Alcohol intake !20 g/d (N5 155) Alcohol intake O20 g/d (N5 143)
n (%) n (%) P
Genotypes .910a
A 50 (32.3) 45 (31.5)
C 1 (0.6) 1 (0.7)
D 92 (59.4) 88 (61.5)
E 5 (3.2) 7 (4.9)
F 7 (4.5) 2 (1.4)
Gender !.001
Female 86 (55.5) 41 (28.7)
Male 88 (44.5) 102 (71.3)
Age mean (95% CI) 43.4 (41.0e45.7) 45.3 (43.1e47.5) .231
Routes of transmission .048
Perinatal 41 (26.5) 30 (21.0)
Sexual 35 (22.6) 21 (14.7)
Intrafamilial 45 (29.0) 42 (29.4)
Unknown 34 (21.9) 50 (35.0)
Viral markers
Anti-HBc positive 154 (99.4) 142 (99.3) 1.000
HBeAg negative 103 (66.5) 118 (82.5) .002
Anti-HBe positive 101 (65.2) 110 (76.9) .035
Viral loadb geometric mean (95% CI) 638,450.9 (349,654.2e1,165,778.9) 306,753.6 (161,280.4e583,500.2) .101
Biochemistry parameters greater than
reference values
ALT 76 (49.7) 94 (66.2) .006
AST 66 (42.9) 92 (64.8) .001
AP 6 (4.0) 16 (11.5) .028
GGT 20 (13.4) 52 (37.4) !.001
Alpha-fetoprotein 6 (4.6) 11 (8.7) .284
Characteristics of biopsy !.001
Necroinflammatory 11 (15.7) 31 (21.7)
Fibrosis 50 (71.4) 31 (21.7)
Esteatosis 9 (12.9) 81 (56.6)
Hematological parameters
Platelet 109/L mean (95% CI) 194.3 (182.7e205.9) 175.3 (160.6e189.9) .042
MCV mean (95% CI) 92.3 (91.2e93.6) 86.7 (85.2e88.3) !.001
PT geometric mean (95% CI) 12.7 (12.4e13.0) 14.0 (13.5e14.5) !.001
ChildePhug’s classification .002c
Grade C 1 (0.7) 4 (3.3)
Grade B 4 (3.0) 15 (12.3)
Othersd 130 (96.3) 103 (84.4)
CI5 confidence interval; ALT5 alanine aminotransferase; AST5 aspartate aminotransferase; AP5 alkaline phosphatase; GGT5 g-glutamyl transpep-
tidase; MCV5mean corpuscular volume; PT5 prothrombin time.
aEvaluated only with genotypes A and D.
bEvaluated only for patients with viral load between 2,000 to 100,000,000 hepatitis B virus DNA copies/mL.
cEvaluated considering Child’s grade equivalent C or B versus others.
dIncluding patients classified as Child grade A and patients without liver disease reported, as reference.
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with alcohol intake above 20 g/day. The distribution of the
presumed sources of transmission of viral infection showed
a marginal significant difference between the two groups of
alcohol intake (P5 .048).
The proportion of individuals with HBeAg negativity
and anti-HBe positivity were significantly higher in the
group with alcohol intake above 20 g/day (P# .035);
however, the proportion of patients with anti-HBc was
similar in the two groups of alcohol intake levels.
Biochemistry parameters like ALT (P5 .006), AST
(P5 .001), GGT (P! .001) were elevated in a significantly
higher proportion of patients in the group with an alcohol
intake above 20 g/day compared with the group with an
alcohol intake under 20 g/day.
Comparison between individuals with alcohol intake
levels less than 20 g/day and greater than 20 g/day showed
significant differences for the frequency of characteristics
of biopsy (P! .001), with a panel of more severity in indi-
viduals with an alcohol intake above 20 g/d.
Evaluation of hematological parameters, showed signifi-
cantly lower values of platelets (P5 .042) and MCV
(P! .001) and significantly higher values of PT (P! .001)
in the group with the higher alcohol consumption level
compared with the group with the lower level of alcohol
consumption.
ChildePhug’s classification showed different results for
both groups, with more severe results for the group with an
alcohol intake above 20 g/day (P5 .002).
For male patients, logistic regression was used to study
the relationship between alcohol intake and liver damage
(Table 2). The outcome was Child’s grade equivalent C or
B versus others, including patients classified as Child grade
A and patients without liver disease reported, as reference.
Alcohol intake was classified as greater than 20 g/day and
less than 20 g/day as reference. For male patients, a positive
marginal significant association was found between liver
damage and alcohol intake (OR: 2.979; 95% CI: 0.938e
9.462; P 5 .064). Significant changes were observed as
a result of the correction for potential confounders (cor-
rected model). Results of the multiple logistic regression
analysis showed a significant positive interaction term in
the model, implying that the effect of higher levels of
alcohol consumption increases with age. The interpretation
of the variable ‘‘alcohol intake’’ is not so simple because of
the interaction term with age. To achieve a better under-
standing, we calculated the estimated ORs for the effect
of alcohol intake in achieving a more severe liver disease,
for different ages (Table 3). The strength of the association
between alcohol intake and liver damage seems to increase
with the age of the patient.
In female patients (Table 2) a strong positive association
between alcohol intake and liver damage was also found
(OR: 9.379; 95% CI: 0.859e468.422; P: .037). When
women were divided into two groups according to their
median age, in the group with ages older than 45 years,
no significant changes in the estimate of the OR were
observed. However, no cases classified as Child’s grade B
or C were observed in the younger group.
Discussion
Alcohol, the only cause of alcoholic liver disease, is also
a known hepatotoxic agent, which may exacerbate liver
injury caused by other agents. The wide prevalence of
alcohol use and abuse in society makes it an important
cofactor in many other liver diseases. Examples of liver
diseases that are significantly influenced by ingestion of
alcohol include chronic viral hepatitis (Balasubramanian
and Kowdley, 2005).
HBV and hepatitis C virus (HCV) are the two most
frequent causes of chronic hepatitis worldwide and lead to
most cases of end-stage liver disease and HCC (Feld and
Liang, 2006; Weisberg et al., 2007). Because of their high
prevalence in the general population, alcohol use and abuse
are often associated with hepatitis virus infections, and in
Table 2
Effect of alcohol intake on the severity of liver disease according to
ChildePugh classificationa with logistic regression
Characteristics OR 95% CI P
Male gender
Crude model:
Alcohol intake (!20 g/d as reference) 2.979 0.938 9.462 .064
Adjusted model:
Alcohol intake (!20 g/d as reference) 0.023 0.000 1.488 .076
Age 0.990 0.925 1.060 .778
Interaction: alcohol intake age 1.106 1.015 1.206 .021
Female gender
Alcohol intake (!20 g/d as reference)c 9.379 0.859 468.422 .037
Less than 45 years:
Alcohol intake (!20 g/d as reference) b
Greater than 45 years:
Alcohol intake (!20 g/d as reference)c 8.000 0.681 406.695 .062
OR5 odds ratio; CI5 confidence interval.
aChild grade equivalent B and C versus others, including patients clas-
sified as Child grade A and patients without liver disease reported, as
reference.
bNot estimated because of all cases being Child grade equivalent A or
without liver disease reported.
cAnalyzed with Fisher exact test and an exact method to construct
confidence limits.
Table 3
Estimated OR by age for the effect of alcohol intake on the severity of liver
disease according to ChildePugh classificationa in male patients
Male age (y) OR
35 0.557
45 1.384
55 3.438
65 8.542
75 21.221
OR5 odds ratio.
aChild grade equivalent B and C versus others, including patients clas-
sified as Child grade A and patients without liver disease reported, as
reference.
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these cases, it has been demonstrated that alcohol plays a role
as a comorbid factor in the development of liver damage and
disease progression (Gramenzi et al., 2006). Moreover,
alcohol abuse in patients with chronic hepatitis B is associ-
ated with increased risk of cirrhosis and HCC (Corrao
et al., 1998; Larkin et al., 2001). Marcellin et al. (2008) found
a strong association between alcohol consumption and
mortality in these patients.
In this study, the association between alcohol intake and
liver damage was analyzed separately for male and female
patients.
No significant differences between the study groups with
alcohol intake levels under and above 20 g/day were
observed with respect to genotype distribution and age.
Genotypes A and D were predominant in both group of
individuals. This distribution is similar to other European
studies that confirm the predominance of these two geno-
types, particularly in Mediterranean countries (Basaras
et al., 2007; Echevarria and Leon, 2004; Sanchez-Tapias
et al., 2002). In our group of individuals, no relationships
between HBV genotypes and the presence of extrahepatic
manifestations were evidenced in patients with chronic
HBV infection. In India, genotype D was reported to be asso-
ciated with more severe liver disease than genotype A and
that may predict occurrence of HBV HCC in young patients
(Kao, 2002). Other European groups (Cacoub et al., 2005) in
this area of investigation found similar results to the Portu-
guese study, and the clinical significance of HBV genotypes
remains largely unknown.
In the group above 20 g/day of alcohol intake, a signifi-
cantly higher percentage of males (P! .001) were observed.
This predominance of male gender is in accordance with
other studies (Livingston and Room, 2009). Males drank at
higher levels than females and behaved more problemati-
cally. However, women are less likely to be suspected of
alcohol abuse, even if they develop withdrawal symptoms
in hospital. There are several reasons for this. Because of
social stigma, women are less likely to admit alcohol abuse,
and they have also more opportunities to ‘‘cover up.’’ Women
can drink when they are at home alone, without their relatives
noticing this behavior (Morgan and Sherlock, 1977).
When the evaluation between routes of infection for
viral hepatitis was performed, the distribution of the
presumed sources of transmission of viral infection showed
a marginal significant difference between the two groups of
alcohol intake (P5 .048). The alcohol intake is also
a cofactor in severity of disease, but it probably does not
affect the route of hepatitis infection. These results are in
concordance with other descriptive epidemiologic studies
of chronic hepatitis B infection, particularly in countries
of Southern Europe (Stefos et al., 2009).
The proportion of individuals with HBeAg negativity
and anti-HBe positivity was significantly higher in the
group with alcohol intake above than 20 g/day (P# .035);
however, the proportion of patients with anti-HBc was
similar in the two groups of alcohol intake levels. These
findings show probably the absence of e-antigen (presum-
ably indicating precore or core promoter mutation). These
results also confirm other epidemiologic observations that
show a higher frequency of HBV serologic markers in
chronic alcoholics compared with the general population.
This may be the result of an increased susceptibility of
alcoholics to infection and/or to an ethanol-mediated stim-
ulation of HBV gene expression and replication.
The biochemical tests considered, ALT, AST, GGT and
AP do not support on its own the diagnosis of alcoholism.
Sensitivities and specificities vary considerably and depend
on the population concerned. GGT continues to remain the
test that combines the greatest convenience and sensitivity;
its diagnostic accuracy can be enhanced by combination
with other traditional markers (AST, ALT, and MCV).
Biochemistry parameters like ALT (P5 .006), AST (P5
0.001), and GGT (P! .001) were elevated in a significantly
higher proportion of patients in the group with an alcohol
intake above 20 g/day, compared with the group with an
alcohol intake less than 20 g/day. Evaluation of hematolog-
ical parameters showed significantly lower values of plate-
lets (P5 .042) and MCV (P! .001) and significantly
higher values of PT (P! .001) in the group with the higher
alcohol consumption level compared with the group with
the lower level of alcohol consumption. All these results
seem to be in accordance with many other studies, particu-
larly in the group of individuals with elevated alcohol
intake (Larkin et al., 2001; Mann et al., 2003).
Comparison between individuals with alcohol intake
levels less than 20 g/day and greater than 20 g/day showed
significant differences for the frequency of characteristics
of biopsy (P! .001), with a panel of more severity in indi-
viduals with an alcohol intake greater than 20 g/day. These
results are in accordance with the results from Childe
Phug’s classification with more severe results for the group
with an alcohol intake greater than 20 g/day (P5 .002) and
other studies in this area including Portugal (Anttila et al.,
2005; Donohue, 2007; Hoek and Pastorino, 2004; Pereira
et al., 1994). These results suggest that the combination
of alcohol abuse and HBV infection increases the histologic
evidence of liver damage.
Liver damage was evaluated using Child’s grading with
Pugh’s modifications. The study of the relationship between
alcohol intake and liver damage in male patients suggests
that the effect of higher levels of alcohol consumption
increases dramatically with age (Table 3). Age and alcohol
were also reported as risk factors to HCC in a large cross-
sectional study performed in Korea and in many others
(Chung et al., 2007; Oliveira et al., 2001; Pereira et al.,
1994; Wang et al., 2003).
The reduced number of female patients classified as
Child’s grade B or C did not allow the analysis of the asso-
ciation of alcohol intake with liver damage adjusted for age.
However, when women were divided in two groups,
according to their median age, cases classified as Child’s
grade B or C were observed only in the older group,
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suggesting an increase of the association between liver
disease and alcohol with the age of the patient.
Other studies found that women tend to present more
severe liver damage, particularly alcoholic hepatitis, and
do so after a shorter period of excessive drinking and at
a lower daily alcohol intake. Differences in body size
composition, and the role of estrogens are responsible for
the greater susceptibility of women, but differences in
immune reactivity between the sexes may also play a part
(Saunders et al., 1981). In this study, the comparison
between genders of the strength of the association between
alcohol and liver damage was not possible. However, for
both genders, this association seems to increase with age.
Hepatitis B infection might influence the development of
liver disease in heavy drinkers in several ways. Firstly,
persistent infection with HBV might potentiate alcohol-
induced liver damage, and there is evidence that this may
occur at fairly low alcohol intakes (Villa et al., 1982).
Secondly, chronic active hepatitis associated with HBsAg
may coexist with alcoholic liver disease, and the two
disease processes would probably result in more rapid
progression to cirrhosis.
On the one hand, infections with HBV and HCV are
a major risk for the development of HCC in excessive
drinkers who should be protected against these viruses
(Nalpas et al., 1998). On the other hand, the two main
causes of liver disease (alcohol and virus) are partially
preventable as they both depend on risk behaviors. Avoid-
ance of alcohol intake is required to eliminate progressive
liver disease in alcoholics. This is best achieved by using
educational and social programs to convince patients and
their caretakers of the great necessity to eliminate alcohol
intake (Leevy and Moroianu, 2005).
The results of this study do not explain the influence of
genotyping pattern in the evolution of the cause of alcoholic
liver disease but indicate that in patients with hepatitis B
infection alcohol is associated with a more severe liver
disease, highlighted in older patients.
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